Biofeedback using electrical impedance tomography during inhalation therapy for chronic obstructive lung disease – a pilot study

Biofeedback using electrical impedance tomography during inhalation therapy for chronic obstructive lung disease – a pilot study - BEIT-IOL

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00037626

Enrollment

Registered

2025-08-11

Start date

2023-05-16

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.9

Interventions

Group 1: COPD stable disease, EIT device connected, monitor not visible, no biofeedback during inhalation Group 2: COPD stable disease, EIT device connected, monitor not visible, biofeedback during in

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis COPD in a stable disease stage, routine outpatient examination, no electronic implants (pacemaker, defibrillator), no pregnancy, no significant language barrier or cognitive impairment (sufficient understanding of EIT), written informed consent.

Exclusion criteria

Exclusion criteria: Pregnancy, electronic implants (pacemaker, defibrillator), missing or withdrawn informed consent, COPD exacerbation.

Design outcomes

Primary

Measure	Time frame
Changes in lung function parameters	—

Secondary

Measure	Time frame
visual changes in EIT Data during Inhalation, subjective benefit	—

Countries

Germany

Contacts

Public ContactAndré Becker

Universitätsklinikum des Saarlandes, Homburg

andre.becker@uks.eu+4968411615804

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 26, 2026